News

Gencure, a subsidiary of BioBridge Global, offers a variety of ways for you to stay connected with us. You can read our latest press releases or the Annual Reports. Visit the Events Page to find out what’s coming up. You can watch a video clip from a newscast, view past events in the Photo Gallery or read industry news. For the social media enthusiast, the BioBridge family is known as “Connect for Life,” and can be found on FacebookTwitterLinkedIn and YouTube. Also, visit our blog here.

Media is welcome to contact the Corporate Communications Department for more information. We offer:

  • 
Interviews with experts in their respective medical fields
  • Interviews with Life Links - community members touched by the services of BioBridge Global
  • Informative tours of the facility

Please contact:
Corporate Communications
Phone: (210) 731-5519
Mobile: (210) 296-9026
Email: crd@biobridgeglobal.org

Recent News Articles

October 18, 2016

Yvonne Ybarra, director of cellular therapy for GenCure, a subsidiary of the San-Antonio based nonprofit biotech BioBridge Global, has been named chair of the Council Advisory Group (CAG) of the National Marrow Donor Program® (NMDP). She took the role on Oct. 1 and is now a voting member of the NMDP board of directors.

The NMDP’s Be The Match® program facilitates transplants of bone marrow and cord blood for those facing leukemia, lymphoma and other blood cancers; conducts research; provides support and resources for patients; and provides education for physicians. Volunteer donors join the marrow registry in hopes of being a match for and donating to a patient in need of a cure. With a swab of the inside of the cheek, donors join people around the world who want to help save lives.

Funds will help develop capability for large-scale manufacturing of stem cells for research and patient use
October 3, 2016

A four-organization biotech group led by San Antonio-based nonprofit BioBridge Global (BBG) has been awarded a $7.8 million contract from the Medical Technology Enterprise Consortium (MTEC). The funds will enable the development of large-scale manufacturing capabilities for clinical-grade stem cells for research and therapeutic use.   

BBG led a group including the U.S. Army Institute of Surgical Research (USAISR) Coagulation and Blood Research, San Antonio biotech firm StemBioSys and Maryland-based RoosterBio Inc. in submitting the proposal for funding.

September 26, 2016

Longtime biomedical industry executive Martin Landon has been named chief executive officer of BioBridge Global (BBG), the nonprofit organization that oversees and supports the South Texas Blood & Tissue Center (STBTC), QualTex Laboratories, GenCure and The Blood & Tissue Center Foundation. The announcement was made today by BBG Board Chair Mike Kreager. 

Landon will join BBG on Oct. 1 and, to ensure a smooth leadership transition, will work with current CEO Linda Myers through the end of the month, Kreager said.  In July, Myers announced plans to retire from the organization.

GenCure marrow donor program joins with The Buckhorn Saloon and Museum and The Texas Ranger Museum for event on Aug. 27
August 19, 2016

South Texans will get a chance to help a retired officer of the Texas Rangers and learn more about the organization at the same time on Saturday, Aug. 27, in downtown San Antonio.

The GenCure marrow donor program is hosting a marrow registry drive in honor of retired Texas Ranger Al Cuellar that day from 11 a.m. to 7 p.m. at The Buckhorn Saloon and Museum and The Texas Ranger Museum, housed together at 318 E. Houston St.

Qualified donors for the registry will receive free admission to the museums the day of the drive. Friends and family members accompanying the registering donor will be admitted for 50 percent off the standard admission. There will also be beer tasting at The Buckhorn Saloon during the event.

Local patient inspires heroes to look further
June 10, 2016

Every day our recruiters and staff reach into the community to do what seems to be the impossible, to save lives. We pound the pavement inspiring strangers to become heroes, while our techs work round the clock to take what our donors selflessly provide (blood, stem cells, tissue) and transform it into lifesaving treatments for patients in need of transfusions, transplants… and, yes, hope.

But what drives us to do this? On any given day our staff could tell you stories of patients that we’ve fought for and have inspired us. Today that patient is Rowan.

Pages